- Canada
- /
- Metals and Mining
- /
- TSX:TMQ
Trilogy Metals (TSX:TMQ) Valuation Check After 2026 Ambler Plan and New US Federal Funding
Reviewed by Simply Wall St
Trilogy Metals (TSX:TMQ) is back on investors radar after outlining its 2026 program and budget for Ambler Metals, paired with a roughly $35.6 million US federal investment into the Upper Kobuk projects.
See our latest analysis for Trilogy Metals.
The Ambler budget update and fresh federal backing come after a powerful run, with Trilogy Metals posting a 90 day share price return of 117.25 percent and a one year total shareholder return of 290.51 percent, signalling momentum is firmly building rather than fading.
If this kind of renewed interest in resource projects has you thinking bigger, it might be worth exploring fast growing stocks with high insider ownership as a way to spot other compelling growth stories early.
With the share price still trading at a sizeable discount to analyst targets despite huge recent gains, is Trilogy Metals quietly undervalued for the next leg of the Ambler story, or is the market already pricing in years of growth?
Price-to-Book of 6x: Is It Justified?
Trilogy Metals last closed at CA$6.17 while trading on a price to book ratio of 6 times, a rich premium versus peers and its sector.
The price to book ratio compares the market value of a company to the accounting value of its net assets. It is a particularly relevant yardstick for early stage explorers with limited or no revenue, as it anchors valuation to the underlying balance sheet rather than profits.
For Trilogy Metals, paying 6 times book value suggests investors are assigning substantial value to future development of the Upper Kobuk projects well beyond the current asset base. This implies the market may be overpricing long dated potential relative to what has actually been de risked so far.
That premium stands out sharply against both the Canadian Metals and Mining industry average of 2.8 times book and a similar 2.8 times average for close peers. This underscores how aggressively the market is capitalising Trilogy Metals’ story compared with comparable names.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-book of 6x (OVERVALUED).
However, investors face meaningful risks, including ongoing losses with no current revenue, as well as potential permitting or development delays at the Upper Kobuk projects.
Find out about the key risks to this Trilogy Metals narrative.
Build Your Own Trilogy Metals Narrative
If you see the numbers differently or want to dig into the details yourself, you can build a personalised view in just minutes, Do it your way.
A great starting point for your Trilogy Metals research is our analysis highlighting 5 important warning signs that could impact your investment decision.
Looking for more investment ideas?
Do not stop at a single story. Use the Simply Wall St Screener to uncover fresh opportunities that other investors may be overlooking.
- Capture early stage upside by scanning these 3608 penny stocks with strong financials that already pair tiny market caps with solid financial foundations.
- Explore structural growth trends by targeting these 29 healthcare AI stocks at the intersection of life sciences, automation, and predictive analytics.
- Find income-focused ideas by reviewing these 13 dividend stocks with yields > 3% that combine dividend yields with sustainable payout profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
The New Payments ETF Is Live on NASDAQ:
Money is moving to real-time rails, and a newly listed ETF now gives investors direct exposure. Fast settlement. Institutional custody. Simple access.
Explore how this launch could reshape portfolios
Sponsored ContentValuation is complex, but we're here to simplify it.
Discover if Trilogy Metals might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About TSX:TMQ
Trilogy Metals
Engages in the exploration and development of mineral properties in the United States.
Flawless balance sheet with moderate risk.
Similar Companies
Market Insights
Weekly Picks
Early mover in a fast growing industry. Likely to experience share price volatility as they scale

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08
Recently Updated Narratives

Title: Market Sentiment Is Dead Wrong — Here's Why PSEC Deserves a Second Look

An amazing opportunity to potentially get a 100 bagger
Amazon: Why the World’s Biggest Platform Still Runs on Invisible Economics
Popular Narratives

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

MicroVision will explode future revenue by 380.37% with a vision towards success
